The evolving donor profile and increasing false-positive rates highlight the need for more specific screening assays and revised donor management strategies. Continuous surveillance and multicenter studies are essential to maintain transfusion safety in an increasingly diverse population.
ŞANLI et al. (Thu,) studied this question.